ATE190620T1 - Erythromycin a 9-o-oxime-derivate mit antibiotischer wirkung - Google Patents

Erythromycin a 9-o-oxime-derivate mit antibiotischer wirkung

Info

Publication number
ATE190620T1
ATE190620T1 AT95941076T AT95941076T ATE190620T1 AT E190620 T1 ATE190620 T1 AT E190620T1 AT 95941076 T AT95941076 T AT 95941076T AT 95941076 T AT95941076 T AT 95941076T AT E190620 T1 ATE190620 T1 AT E190620T1
Authority
AT
Austria
Prior art keywords
erythromycin
oxime derivatives
antibiotic action
antibiotic
action
Prior art date
Application number
AT95941076T
Other languages
English (en)
Inventor
Franco Pellacini
Giovanna Schioppacassi
Enrico Albini
Daniela Botta
Stefano Romagnano
Francesco Santangelo
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE190620T1 publication Critical patent/ATE190620T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT95941076T 1994-12-13 1995-12-07 Erythromycin a 9-o-oxime-derivate mit antibiotischer wirkung ATE190620T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT94MI002496A IT1276901B1 (it) 1994-12-13 1994-12-13 Derivati dell'eritromicina a 9-0-ossina dotati di attivita' antibiotica
PCT/EP1995/004815 WO1996018633A1 (en) 1994-12-13 1995-12-07 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity

Publications (1)

Publication Number Publication Date
ATE190620T1 true ATE190620T1 (de) 2000-04-15

Family

ID=11369979

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95941076T ATE190620T1 (de) 1994-12-13 1995-12-07 Erythromycin a 9-o-oxime-derivate mit antibiotischer wirkung

Country Status (35)

Country Link
US (1) US5847092A (de)
EP (1) EP0797579B1 (de)
JP (1) JPH10510520A (de)
KR (1) KR100367559B1 (de)
CN (1) CN1046535C (de)
AP (1) AP739A (de)
AT (1) ATE190620T1 (de)
AU (1) AU690791B2 (de)
BG (1) BG63261B1 (de)
BR (1) BR9510015A (de)
CA (1) CA2207029A1 (de)
CZ (1) CZ289943B6 (de)
DE (1) DE69515694T2 (de)
DK (1) DK0797579T3 (de)
EE (1) EE03401B1 (de)
ES (1) ES2144154T3 (de)
FI (1) FI972493A (de)
GE (1) GEP20012391B (de)
GR (1) GR3033622T3 (de)
HU (1) HU220631B1 (de)
IT (1) IT1276901B1 (de)
LT (1) LT4276B (de)
LV (1) LV11898B (de)
MD (1) MD1788G2 (de)
NO (1) NO309816B1 (de)
NZ (1) NZ297446A (de)
OA (1) OA10491A (de)
PL (1) PL182053B1 (de)
PT (1) PT797579E (de)
RO (1) RO116282B1 (de)
RU (1) RU2152951C1 (de)
SI (1) SI9520124A (de)
TJ (1) TJ306B (de)
UA (1) UA48958C2 (de)
WO (1) WO1996018633A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290447B1 (it) 1997-03-28 1998-12-03 Zambon Spa Derivati 1,3-ossatiolanici ad attivita' antivirale
IT1301967B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivato di eritromicina ad attivita' antibiotica
IT1301968B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Derivati di eritromicina ad attivita' antibiotica
IT1306205B1 (it) * 1999-01-15 2001-05-30 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US6947844B2 (en) 2000-08-09 2005-09-20 Yale University Modulators of ribosomal function and identification thereof
US6638908B1 (en) 2000-08-09 2003-10-28 Yale University Crystals of the large ribosomal subunit
IL151012A0 (en) 2001-08-03 2003-02-12 Ribosomes Structure And Protei Ribosomes structure and protein synthesis inhibitors
US6952650B2 (en) 2001-08-03 2005-10-04 Yale University Modulators of ribosomal function and identification thereof
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
CN102816194A (zh) 2004-02-27 2012-12-12 瑞伯-X医药品有限公司 大环化合物以及其制作和使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
GB8521402D0 (en) 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4740502A (en) * 1986-06-20 1988-04-26 Abbott Laboratories Semisynthetic erythromycin antibiotics
KR880009960A (ko) 1987-02-24 1988-10-06 데이빗 로버츠 화학적 화합물
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CZ178697A3 (en) 1997-12-17
DE69515694T2 (de) 2000-10-26
KR100367559B1 (ko) 2003-04-21
AP739A (en) 1999-03-24
SI9520124A (sl) 1998-04-30
WO1996018633A1 (en) 1996-06-20
CZ289943B6 (cs) 2002-04-17
DE69515694D1 (de) 2000-04-20
NZ297446A (en) 1999-06-29
NO972702L (no) 1997-08-13
FI972493A0 (fi) 1997-06-12
NO972702D0 (no) 1997-06-12
DK0797579T3 (da) 2000-06-05
MX9704253A (es) 1997-09-30
MD970243A (en) 1999-05-31
BG101570A (en) 1998-02-27
HU220631B1 (hu) 2002-03-28
EP0797579B1 (de) 2000-03-15
IT1276901B1 (it) 1997-11-03
EP0797579A1 (de) 1997-10-01
RU2152951C1 (ru) 2000-07-20
PT797579E (pt) 2000-08-31
LT97116A (en) 1997-10-27
CA2207029A1 (en) 1996-06-20
LT4276B (lt) 1998-01-26
JPH10510520A (ja) 1998-10-13
RO116282B1 (ro) 2000-12-29
EE9700124A (et) 1997-12-15
AP9700989A0 (en) 1997-07-31
UA48958C2 (uk) 2002-09-16
CN1169727A (zh) 1998-01-07
US5847092A (en) 1998-12-08
NO309816B1 (no) 2001-04-02
OA10491A (en) 2002-04-10
GEP20012391B (en) 2001-03-25
MD1788F2 (en) 2001-11-30
MD1788G2 (ro) 2002-05-31
AU4260396A (en) 1996-07-03
FI972493A (fi) 1997-06-12
PL320688A1 (en) 1997-10-27
TJ306B (en) 2001-08-06
AU690791B2 (en) 1998-04-30
CN1046535C (zh) 1999-11-17
GR3033622T3 (en) 2000-10-31
BG63261B1 (bg) 2001-07-31
ITMI942496A1 (it) 1996-06-13
BR9510015A (pt) 1997-10-28
PL182053B1 (pl) 2001-10-31
HUT77126A (hu) 1998-03-02
LV11898B (en) 1998-03-20
ES2144154T3 (es) 2000-06-01
ITMI942496A0 (it) 1994-12-13
LV11898A (lv) 1997-12-20
EE03401B1 (et) 2001-04-16

Similar Documents

Publication Publication Date Title
DE69528704D1 (de) Lipidsenkende 1,4-benzothiazepin-1,1-dioxide
NO993876D0 (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
EP0525083A4 (en) Erythromycin derivatives
IS5251A (is) 9-oxím erýþrómýsín afleiður
FR2646203B1 (fr) Store a enrouleur motorise
IL129946A0 (en) Erythromycin a derivatives
DK76193D0 (da) Kulhydratderivater
NO980016D0 (no) Makrolider
DE69821009D1 (de) 6,9-verbrückte erythromycin-derivate
ATE239750T1 (de) 6,11-verbrückte erythromycinderivate
DE59600603D1 (de) Lamellensynchronisierung
ATE190620T1 (de) Erythromycin a 9-o-oxime-derivate mit antibiotischer wirkung
FR2723140B1 (fr) Store a enrouleur
DE9315501U1 (de) Kurvenrolle
DE29500340U1 (de) Doppelgreifer
DE9309396U1 (de) Kurvenrolle
DE9318065U1 (de) Greifer
PT984975E (pt) Derivados de eritromicina multiciclicos
KR940022906U (ko) 블라인드
LV10450A (lv) O-heteroaril- O-alkilheteroaril- O-alkenilheteroaril- un O-alkinilheteroaril- makrolidi
DE9318180U1 (de) Kurvenrolle
KR950004230U (ko) 회전 소각로
ITMI922531A1 (it) Antibiotici derivati della eritromicina a 9-ossima
BR1100453A (pt) derivados de eritromicina
DE9418270U1 (de) Antibiotika-Schieber

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee